ロード中...
Editing the Central Nervous System Through CRISPR/Cas9 Systems
The translational gap to treatments based on gene therapy has been reduced in recent years because of improvements in gene editing tools, such as the CRISPR/Cas9 system and its variations. This has allowed the development of more precise therapies for neurodegenerative diseases, where access is priv...
保存先:
| 出版年: | Front Mol Neurosci |
|---|---|
| 主要な著者: | , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Frontiers Media S.A.
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6546027/ https://ncbi.nlm.nih.gov/pubmed/31191241 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fnmol.2019.00110 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|